BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 33973518)

  • 1. Limited inhibition of multiple nodes in a driver network blocks metastasis.
    Yesilkanal AE; Yang D; Valdespino A; Tiwari P; Sabino AU; Nguyen LC; Lee J; Xie XH; Sun S; Dann C; Robinson-Mailman L; Steinberg E; Stuhlmiller T; Frankenberger C; Goldsmith E; Johnson GL; Ramos AF; Rosner MR
    Elife; 2021 May; 10():. PubMed ID: 33973518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7.
    Dangi-Garimella S; Yun J; Eves EM; Newman M; Erkeland SJ; Hammond SM; Minn AJ; Rosner MR
    EMBO J; 2009 Feb; 28(4):347-58. PubMed ID: 19153603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity.
    Noh HS; Hah YS; Ha JH; Kang MY; Zada S; Rha SY; Kang SS; Kim HJ; Park JY; Byun JH; Hahm JR; Shin JK; Jeong SH; Lee YJ; Kim DR
    Oncotarget; 2016 Jan; 7(4):4632-46. PubMed ID: 26716415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raf kinase inhibitor protein (RKIP) in cancer.
    Escara-Wilke J; Yeung K; Keller ET
    Cancer Metastasis Rev; 2012 Dec; 31(3-4):615-20. PubMed ID: 22684368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signalling pathway for RKIP and Let-7 regulates and predicts metastatic breast cancer.
    Yun J; Frankenberger CA; Kuo WL; Boelens MC; Eves EM; Cheng N; Liang H; Li WH; Ishwaran H; Minn AJ; Rosner MR
    EMBO J; 2011 Aug; 30(21):4500-14. PubMed ID: 21873975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Network of mutually repressive metastasis regulators can promote cell heterogeneity and metastatic transitions.
    Lee J; Lee J; Farquhar KS; Yun J; Frankenberger CA; Bevilacqua E; Yeung K; Kim EJ; Balázsi G; Rosner MR
    Proc Natl Acad Sci U S A; 2014 Jan; 111(3):E364-73. PubMed ID: 24395801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RKIP Inhibits Local Breast Cancer Invasion by Antagonizing the Transcriptional Activation of MMP13.
    Datar I; Feng J; Qiu X; Lewandowski J; Yeung M; Ren G; Aras S; Al-Mulla F; Cui H; Trumbly R; Arudra SK; De Las Casas LE; de la Serna I; Bitar MS; Yeung KC
    PLoS One; 2015; 10(8):e0134494. PubMed ID: 26308852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raf kinase inhibitor protein mediated signaling inhibits invasion and metastasis of hepatocellular carcinoma.
    Wu X; Yang Y; Xu Z; Li J; Yang B; Feng N; Zhang Y; Wang S
    Biochim Biophys Acta; 2016 Feb; 1860(2):384-91. PubMed ID: 26116914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raf kinase inhibitor protein regulation of raf and MAPK signaling.
    Hagan S; Garcia R; Dhillon A; Kolch W
    Methods Enzymol; 2006; 407():248-59. PubMed ID: 16757329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raf kinase inhibitory protein regulates Raf-1 but not B-Raf kinase activation.
    Trakul N; Menard RE; Schade GR; Qian Z; Rosner MR
    J Biol Chem; 2005 Jul; 280(26):24931-40. PubMed ID: 15886202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raf kinase inhibitor protein (RKIP) deficiency decreases latency of tumorigenesis and increases metastasis in a murine genetic model of prostate cancer.
    Escara-Wilke J; Keller JM; Ignatoski KM; Dai J; Shelley G; Mizokami A; Zhang J; Yeung ML; Yeung KC; Keller ET
    Prostate; 2015 Feb; 75(3):292-302. PubMed ID: 25327941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raf kinase inhibitory protein (RKIP) as a metastasis suppressor: regulation of signaling networks in cancer.
    Yesilkanal AE; Rosner MR
    Crit Rev Oncog; 2014; 19(6):447-54. PubMed ID: 25597354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor suppressor RKIP inhibits prostate cancer cell metastasis and sensitizes prostate cancer cells to docetaxel treatment.
    Zhu CX; Li WZ; Guo YL; Chen L; Li GH; Yu JJ; Shu B; Peng S
    Neoplasma; 2018; 65(2):228-233. PubMed ID: 29534584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gemifloxacin inhibits migration and invasion and induces mesenchymal-epithelial transition in human breast adenocarcinoma cells.
    Chen TC; Hsu YL; Tsai YC; Chang YW; Kuo PL; Chen YH
    J Mol Med (Berl); 2014 Jan; 92(1):53-64. PubMed ID: 24005829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of RKIP expression promotes nasopharyngeal carcinoma invasion and metastasis by activating Stat3 signaling.
    He QY; Yi HM; Yi H; Xiao T; Qu JQ; Yuan L; Zhu JF; Li JY; Wang YY; Li LN; Feng J; Lu SS; Xiao ZQ
    Oncotarget; 2015 Jun; 6(18):16422-36. PubMed ID: 25915430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RKIP and HMGA2 regulate breast tumor survival and metastasis through lysyl oxidase and syndecan-2.
    Sun M; Gomes S; Chen P; Frankenberger CA; Sankarasharma D; Chung CH; Chada KK; Rosner MR
    Oncogene; 2014 Jul; 33(27):3528-37. PubMed ID: 23975428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of raf kinase inhibitor protein expression on metastasis and progression of human epithelial ovarian cancer.
    Li HZ; Wang Y; Gao Y; Shao J; Zhao XL; Deng WM; Liu YX; Yang J; Yao Z
    Mol Cancer Res; 2008 Jun; 6(6):917-28. PubMed ID: 18567796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RKIP regulates MAP kinase signaling in cells with defective B-Raf activity.
    Zeng L; Ehrenreiter K; Menon J; Menard R; Kern F; Nakazawa Y; Bevilacqua E; Imamoto A; Baccarini M; Rosner MR
    Cell Signal; 2013 May; 25(5):1156-65. PubMed ID: 23416466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting mitogen-activated protein kinase/extracellular signal-regulated kinase kinase in the mutant (V600E) B-Raf signaling cascade effectively inhibits melanoma lung metastases.
    Sharma A; Tran MA; Liang S; Sharma AK; Amin S; Smith CD; Dong C; Robertson GP
    Cancer Res; 2006 Aug; 66(16):8200-9. PubMed ID: 16912199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raf kinase inhibitor protein suppresses nuclear factor-κB-dependent cancer cell invasion through negative regulation of matrix metalloproteinase expression.
    Beshir AB; Ren G; Magpusao AN; Barone LM; Yeung KC; Fenteany G
    Cancer Lett; 2010 Dec; 299(2):137-49. PubMed ID: 20855151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.